The role of calsyntenin‐3 in dystrophic neurite formation in  A lzheimer's disease brain | Zendy

Uchida Yoko | Zendy; Gomi Fujiya | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

The role of calsyntenin‐3 in dystrophic neurite formation in A lzheimer's disease brain

Author(s) -

Uchida Yoko,

Gomi Fujiya

Publication year - 2016

Publication title -

geriatrics and gerontology international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.823

H-Index - 57

eISSN - 1447-0594

pISSN - 1444-1586

DOI - 10.1111/ggi.12737

Subject(s) - neurite , senile plaques , pathogenesis , neuroscience , medicine , pathological , disease , alzheimer's disease , mechanism (biology) , amyloid (mycology) , degenerative disease , pathology , psychology , biology , biochemistry , philosophy , epistemology , in vitro

β‐Amyloid ( A β) oligomers may play an important role in the early pathogenesis of Alzheimer's disease: cognitive impairment caused by synaptic dysfunction. Dystrophic neurites surrounding A β plaques, another pathological feature of A lzheimer's disease, are plaque‐associated neuritic alterations preceding the appearance of synaptic loss. In the present review, we focus on the mechanism of dystrophic neurite formation by A ß oligomers, and discuss the neurotoxic role of A β‐induced calsyntenin‐3 in mediating dystrophic neurite formation. Geriatr Gerontol Int 2016; 16 (Suppl. 1): 43–50.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research